ZA971740B - Morphine and diamorphine salts of anionic non-narcotic analgesics of the type substituted carboxylic acids, processes for their production, their use, and pharmaceutical preparations comprising these salts. - Google Patents

Morphine and diamorphine salts of anionic non-narcotic analgesics of the type substituted carboxylic acids, processes for their production, their use, and pharmaceutical preparations comprising these salts.

Info

Publication number
ZA971740B
ZA971740B ZA9701740A ZA971740A ZA971740B ZA 971740 B ZA971740 B ZA 971740B ZA 9701740 A ZA9701740 A ZA 9701740A ZA 971740 A ZA971740 A ZA 971740A ZA 971740 B ZA971740 B ZA 971740B
Authority
ZA
South Africa
Prior art keywords
salts
morphine
diamorphine
processes
production
Prior art date
Application number
ZA9701740A
Other languages
English (en)
Inventor
Bodo Asmussen
Walter Mueller
Walter Riess
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA971740B publication Critical patent/ZA971740B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9701740A 1996-02-28 1997-02-27 Morphine and diamorphine salts of anionic non-narcotic analgesics of the type substituted carboxylic acids, processes for their production, their use, and pharmaceutical preparations comprising these salts. ZA971740B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19607395A DE19607395C2 (de) 1996-02-28 1996-02-28 Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate

Publications (1)

Publication Number Publication Date
ZA971740B true ZA971740B (en) 1997-09-04

Family

ID=7786595

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9701740A ZA971740B (en) 1996-02-28 1997-02-27 Morphine and diamorphine salts of anionic non-narcotic analgesics of the type substituted carboxylic acids, processes for their production, their use, and pharmaceutical preparations comprising these salts.

Country Status (20)

Country Link
US (1) US6156764A (ko)
EP (1) EP0883619B1 (ko)
JP (1) JP4624497B2 (ko)
KR (1) KR100422276B1 (ko)
CN (1) CN1064363C (ko)
AT (1) ATE212024T1 (ko)
AU (1) AU712255B2 (ko)
CZ (1) CZ294401B6 (ko)
DE (2) DE19607395C2 (ko)
DK (1) DK0883619T3 (ko)
ES (1) ES2171886T3 (ko)
HU (1) HU225268B1 (ko)
IL (1) IL125819A (ko)
NO (1) NO983864L (ko)
NZ (1) NZ331485A (ko)
PL (1) PL185915B1 (ko)
PT (1) PT883619E (ko)
SK (1) SK104398A3 (ko)
WO (1) WO1997031918A1 (ko)
ZA (1) ZA971740B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001517669A (ja) * 1997-09-25 2001-10-09 エルティエス ローマン テラピー−ズュステーメ アーゲー モルヒネアルカロイド類の酸添加塩類およびその応用
AR034362A1 (es) * 2001-06-05 2004-02-18 Control Delivery Systems Compuestos analgesicos de liberacion prolongada
BR0213357A (pt) * 2001-10-18 2004-10-26 Novartis Ag Compostos orgânicos
WO2003043657A1 (en) * 2001-11-19 2003-05-30 Control Delivery Systems, Inc. Topical delivery of codrugs
MXPA04006875A (es) * 2002-01-18 2004-12-06 Control Delivery Sys Inc Sistema de gel polimerico para suministro controlado de cofarmacos.
US8557291B2 (en) * 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
CA2491572C (en) * 2002-07-05 2010-03-23 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8840928B2 (en) * 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
DE602004016995D1 (de) * 2003-06-26 2008-11-20 Control Delivery Sys Inc In-situ gelierendes arzneimittelabgabesystem
TWI367103B (en) 2003-06-26 2012-07-01 Psivida Inc Bioerodible sustained release drug delivery systems
US20050196455A1 (en) * 2003-10-27 2005-09-08 Jianbing Chen Suspension delivery system for the sustained and controlled local release of pharmaceuticals
SI1765292T1 (en) 2004-06-12 2018-04-30 Collegium Pharmaceutical, Inc. Formulations of medicines to discourage abuse
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404209A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and sulindac
GB8319546D0 (en) * 1983-07-20 1983-08-24 Euro Celtique Sa Pharmaceutical active salts
ZA893422B (en) * 1988-02-24 1991-01-30 Adcock Ingram Lab Ltd Pharmaceutical composition
TW225536B (ko) * 1990-08-23 1994-06-21 Ciba Geigy Ag
JPH06506198A (ja) * 1991-03-04 1994-07-14 ワーナー−ランバート・コンパニー 種々な剤形の非ステロイド性抗炎症剤の新規な塩／イオン対
US5256669A (en) * 1992-08-07 1993-10-26 Aminotek Sciences, Inc. Methods and compositions for treating acute or chronic pain and drug addiction
SE9301057L (sv) * 1993-03-30 1994-10-01 Pharmacia Ab Beredning med kontrollerad frisättning
FR2708611B1 (fr) * 1993-07-29 1995-10-27 Meram Lab Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
GB9319568D0 (en) * 1993-09-22 1993-11-10 Euro Celtique Sa Pharmaceutical compositions and usages
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy

Also Published As

Publication number Publication date
CN1064363C (zh) 2001-04-11
DK0883619T3 (da) 2002-04-29
WO1997031918A1 (de) 1997-09-04
DE59706015D1 (de) 2002-02-21
PL185915B1 (pl) 2003-08-29
IL125819A (en) 2002-04-21
EP0883619A1 (de) 1998-12-16
NO983864D0 (no) 1998-08-21
HUP9900568A2 (hu) 1999-06-28
DE19607395A1 (de) 1997-09-04
JP4624497B2 (ja) 2011-02-02
NO983864L (no) 1998-08-21
PT883619E (pt) 2002-07-31
HU225268B1 (en) 2006-08-28
CZ265798A3 (cs) 1998-11-11
PL328712A1 (en) 1999-02-15
DE19607395C2 (de) 2002-11-21
CZ294401B6 (cs) 2004-12-15
SK104398A3 (en) 1998-12-02
CN1212698A (zh) 1999-03-31
NZ331485A (en) 1999-03-29
IL125819A0 (en) 1999-04-11
US6156764A (en) 2000-12-05
HUP9900568A3 (en) 2001-08-28
AU712255B2 (en) 1999-11-04
ES2171886T3 (es) 2002-09-16
AU1769597A (en) 1997-09-16
JP2000505463A (ja) 2000-05-09
EP0883619B1 (de) 2002-01-16
KR19990087343A (ko) 1999-12-27
KR100422276B1 (ko) 2004-07-30
ATE212024T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
ZA971740B (en) Morphine and diamorphine salts of anionic non-narcotic analgesics of the type substituted carboxylic acids, processes for their production, their use, and pharmaceutical preparations comprising these salts.
AU2614995A (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
BR9406941A (pt) Formulação oral com revestimento entèrico processo para a preparação da formulação processo para a inibição da secreção de acido gástrico em mamiferos e no homem e processo para o tratamento de doencas relacionados ao ácidos gástrico em mamiferos e no homem
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
AU6039194A (en) Imidazopyridines and their use in treating gastrointestinal diseases
GR3024344T3 (en) A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent.
IL113631A0 (en) New antagonist compounds
AU3092397A (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
NO982778L (no) Morfinderivater med smertestillende virkning
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
AU1870397A (en) Novel monofunctionalised edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
FI956269A0 (fi) Ropivakaiinin käyttö kipua lievittävän vaikutuksen omaavan ja häviävän vähäisen motoriikan estymisen aikaansaavan farmaseuttisen tuotteen valmistukseen
GB9516073D0 (en) Pharmaceutical composition
CA2247616A1 (en) Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type
IL117083A0 (en) Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical agents containing these compounds
DE59702821D1 (en) Dimethyl-substituierte cyclohexandienderivate
PL322847A1 (en) Condensed b-carbolins
AU1195497A (en) Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic